ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,271.92
-0.64%
US Tech 100
18,278.00
-0.59%
Dow Jones
38,463.20
-1.00%
Brent Oil
83.24
-1.29%
Bitcoin
67,290.35
-1.47%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Codexis Inc (CDXS)

  7. Codexis Inc (CDXS) News

CDXS

Codexis (CDXS)

Codexis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CDXS
DateTimeSourceHeadlineSymbolCompany
05/22/20244:25PMGlobeNewswire Inc.Codexis to Participate in Jefferies Global Healthcare ConferenceNASDAQ:CDXSCodexis Inc
05/20/20244:05PMGlobeNewswire Inc.Codexis to Participate in TD Cowen 2nd Annual Sustainability WeekNASDAQ:CDXSCodexis Inc
05/14/20249:11AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CDXSCodexis Inc
05/14/20246:52AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
05/14/20246:00AMGlobeNewswire Inc.Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual MeetingNASDAQ:CDXSCodexis Inc
05/02/20244:05PMGlobeNewswire Inc.Codexis Reports First Quarter 2024 Financial ResultsNASDAQ:CDXSCodexis Inc
04/18/20244:05PMGlobeNewswire Inc.Codexis to Report First Quarter 2024 Financial Results on May 2NASDAQ:CDXSCodexis Inc
04/11/20247:05AMGlobeNewswire Inc.Codexis Appoints Carole Cobb, MBA, to Strategic Advisory BoardNASDAQ:CDXSCodexis Inc
03/06/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
02/28/20244:05PMGlobeNewswire Inc.Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:CDXSCodexis Inc
02/27/202412:15PMAllPennyStocks.comBiotech Rallied Strongly On Exclusive Licensing AgreementNASDAQ:CDXSCodexis Inc
02/26/20244:05PMGlobeNewswire Inc.Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with RocheNASDAQ:CDXSCodexis Inc
02/26/20248:05AMGlobeNewswire Inc.Codexis to Participate in TD Cowen 44th Annual Health Care ConferenceNASDAQ:CDXSCodexis Inc
02/20/20248:05AMGlobeNewswire Inc.Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory BoardNASDAQ:CDXSCodexis Inc
02/16/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
02/14/20244:51PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CDXSCodexis Inc
02/14/20244:05PMGlobeNewswire Inc.Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28NASDAQ:CDXSCodexis Inc
02/13/20244:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
02/13/20244:05PMGlobeNewswire Inc.Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key MilestonesNASDAQ:CDXSCodexis Inc
02/09/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
02/01/20244:05PMGlobeNewswire Inc.seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General MeetingNASDAQ:CDXSCodexis Inc
01/24/20242:27PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CDXSCodexis Inc
01/09/20248:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
01/02/20249:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
01/02/20249:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
01/02/20249:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
01/02/20249:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
12/27/20238:30AMGlobeNewswire Inc.Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108NASDAQ:CDXSCodexis Inc
12/27/20238:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
12/13/20234:06PMGlobeNewswire Inc.Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA PolymeraseNASDAQ:CDXSCodexis Inc
 Showing the most relevant articles for your search:NASDAQ:CDXS

Your Recent History

BIT
P117P5
Bnp Paribas Issuance
TKOK
TIENUSDT
TiEN Token
BOV
KLBN3
KLABIN ON
BIT
P117R1
Bnp Paribas Issuance
LSE
SD52
Hsbc Bk 23
USOTC
RGBPP
Regen Biopharma (PK)
LSE
47SB
Hsbc Bk.24
COIN
PSDNETH
Poseidon H2O Governance Token
BOV
ORCL34
Oracle
BIT
I05662
Banca Imi
COIN
SUIEUR
SUI Network
BIT
S28707
Societe Generale Effekten
LSE
SUSD
Spdr Uscorp0-3
BIT
S27006
Societe Generale Effekten
BIT
I08643
Intesa Sanpaolo
BIT
P1H586
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved